Collibra, a data governance software spinout of VUB, has closed a $58m series D round to accelerate its expansion plans and product development.

KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Cash Capital.

Northwestern University and Osage University Partners both returned to back a $70m series B for Aptinyx, having previously contributed to a $65m series A round in May 2016.

GV has joined the investors in oncology treatment developer Relay Therapeutics, which has now raised $120m altogether.

NEA has led a series B round for cancer treatment developer Pionyr Immunotherapeutics, co-founded by researchers from UC San Francisco and University of Toronto.

UC-RNT, an investment fund established by University of California and Ratan Tata, has contributed to a funding round for NestAway, whose shareholders already include Flipkart.

Alaska Permanent Fund and Qatar Investment Authority were among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.

Novo and Sanofi have backed a series A round for Inozyme Pharma, which is developing treatments for rare diseases affecting infants based on research at Yale.